Patents by Inventor Robin Bannister

Robin Bannister has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions for inhalation
    Patent number: 10449161
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: October 22, 2019
    Assignee: VECTURA LIMITED
    Inventors: John Nicholas Staniforth, Haggis Harris, David Alexander Vodden Morton, Robin Bannister
  • Pharmaceutical compositions for inhalation
    Patent number: 10188612
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: January 29, 2019
    Assignee: Vectura Limited
    Inventors: John Nicholas Staniforth, Haggis Harris, David Alexander Vodden Morton, Robin Bannister
  • PHARMACEUTICAL COMPOSITIONS FOR INHALATION
    Publication number: 20170172947
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Application
    Filed: March 9, 2017
    Publication date: June 22, 2017
    Inventors: JOHN NICHOLAS STANIFORTH, HAGGIS HARRIS, DAVID ALEXANDER VODDEN MORTON, ROBIN BANNISTER
  • PHARMACEUTICAL COMPOSITIONS FOR INHALATION
    Publication number: 20150086640
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Application
    Filed: November 20, 2014
    Publication date: March 26, 2015
    Inventors: JOHN NICHOLAS STANIFORTH, HAGGIS HARRIS, DAVID ALEXANDER VODDEN MORTON, ROBIN BANNISTER
  • Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
    Patent number: 8932635
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: January 13, 2015
    Assignee: Vectura Limited
    Inventors: John Nicholas Staniforth, Haggis Harris, David Alexander Vodden Morton, Robin Bannister
  • Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation
    Patent number: 8435567
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for Pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Grant
    Filed: October 7, 2011
    Date of Patent: May 7, 2013
    Assignee: Vectura Limited
    Inventors: John Nicholas Staniforth, Haggis Harris, David Alexander Vodden Morton, Robin Bannister
  • Pharmaceutical Compositions for Inhalation
    Publication number: 20120027863
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for Pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Application
    Filed: October 7, 2011
    Publication date: February 2, 2012
    Applicant: Vectura Limited
    Inventors: John Nicholas STANIFORTH, Haggis Harris, David Alexander Vodden Morton, Robin Bannister
  • Pharmaceutical compositions for inhalation
    Patent number: 8048451
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: November 1, 2011
    Assignee: Vectura Limited
    Inventors: John Nicholas Staniforth, Haggis Harris, David Alexander Vodden Morton, Robin Bannister
  • Treatment of Respiratory Disease
    Publication number: 20080020048
    Abstract: Glycopyrrate or an analogue thereof is useful for the treatment of bronchospasm or as a rescue medication.
    Type: Application
    Filed: May 10, 2005
    Publication date: January 24, 2008
    Inventors: Susan Snape, Robin Bannister
  • Treatment of Childhood Asthma
    Publication number: 20070243260
    Abstract: Glycopyrrolate or an analogue thereof is useful for the treatment of childhood asthma.
    Type: Application
    Filed: May 10, 2005
    Publication date: October 18, 2007
    Inventors: Susan Snape, Robin Bannister
  • Pharmaceutical Composition Of (+)-Erythro-Mefloquine And Its Use
    Publication number: 20070202503
    Abstract: A pharmaceutical composition is in the form of a unit dosage comprising 1 to 60 mg (+)-erythro-mefloquine. This is intended for daily dosing.
    Type: Application
    Filed: March 17, 2005
    Publication date: August 30, 2007
    Inventors: Helen Baker, Robin Bannister
  • Use of ifenprodril in the treatment of pain
    Publication number: 20070043111
    Abstract: Ifenprodil is useful for the treatment of pain.
    Type: Application
    Filed: October 21, 2004
    Publication date: February 22, 2007
    Inventors: John Brew, Robin Bannister, Andrew Baxter, Alan Rothaul, Michael Lyne
  • Use of non-opiates for the potentation of opiates
    Publication number: 20070043112
    Abstract: A non-opioid analgesic is used for the treatment of intermittent or episodic pain experienced by a patient undergoing chronic pain treatment with an opioid analgesic.
    Type: Application
    Filed: October 21, 2004
    Publication date: February 22, 2007
    Inventors: John Brew, Robin Bannister, Andrew Baxter, Alan Rothaul, Michael Lyne
  • Treatment of inflammatory disorders
    Publication number: 20060074106
    Abstract: A method of treating an inflammatory disease or an autoimmune disease in a subject, comprises the administration of mefloquine.
    Type: Application
    Filed: November 30, 2005
    Publication date: April 6, 2006
    Inventors: Benjamin Skead, Robin Bannister, Alan Rothaul
  • Use of nefopam for the treatment of nausea or emesis
    Publication number: 20060063753
    Abstract: The invention relates to the use of nefopam for the manufacture of a medicament for the treatment of nausea, dizziness, blurred vision and emesis.
    Type: Application
    Filed: June 17, 2003
    Publication date: March 23, 2006
    Inventors: Robin Bannister, Michael Lyne
  • Treatment of pain with ifendropil
    Publication number: 20050222205
    Abstract: Ifenprodil is useful for the treatment of pain, e.g. on administration intranasally or by another route that avoids first-pass metabolism.
    Type: Application
    Filed: May 6, 2003
    Publication date: October 6, 2005
    Inventors: John Brew, Robin Bannister, Andrew Douglas Baxter, Alan Rothaul, Michael Lyne
  • Treatment of respiratory diseases
    Publication number: 20050019271
    Abstract: A pharmaceutical composition for pulmonary delivery comprises glycopyrrolate in a controlled release formulation, wherein, on administration, the glycopyrrolate exerts its pharmacological effect over a period greater than 12 hours.
    Type: Application
    Filed: August 24, 2004
    Publication date: January 27, 2005
    Inventors: Robin Bannister, Andrew Richards, Julian Gilbert, David Morton, John Staniforth
  • Pharmaceutical compositions for inhalation
    Publication number: 20040047810
    Abstract: The invention provides microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the dissolution of the active substance. The invention also provides a method for making the microparticles.
    Type: Application
    Filed: September 12, 2003
    Publication date: March 11, 2004
    Inventors: John Nicholas Staniforth, Haggis Harris, David Alexander Vodden Morton, Robin Bannister